COX-2 oxidative metabolism of endocannabinoids augments hippocampal synaptic plasticity

Molecular and Cellular Neuroscience

Volumn 37, Issue 4, 2008, Pages 682-695

  Yang, Hongwei ^a   Zhang, Jian ^a   Andreasson, Katrin ^b   Chen, Chu ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Endogenous cannabinoids; Long term potentiation; Prostaglandin

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ENDOCANNABINOID; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; PROSTAGLANDIN E2;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPOLARIZATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE DELETION; HIPPOCAMPUS; LONG TERM POTENTIATION; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNAPTIC TRANSMISSION; TRANSGENE;

ANIMALS; CYCLOOXYGENASE 2; ENDOCANNABINOIDS; HIPPOCAMPUS; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEURONAL PLASTICITY; OXIDATION-REDUCTION; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 41149100968     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2007.12.019     Document Type: Article

References (38)

1. Akaneya Y., and Tsumoto T. Bidirectional trafficking of prostaglandin E2 receptors involved in long-term potentiation in visual cortex. J. Neurosci. 26 (2006) 10209-10221
2. Alger B.E. Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids. Prog. Neurobiol. 68 (2002) 247-286
3. Alger B.E. Endocannabinoid identification in the brain: studies of breakdown lead to breakthrough, and there may be NO hope. Sci. STKE pe 51 (2005) 1-4
4. Andreasson K.I., Savoneko A., Vidensky S., Goellner J.J., Yang Y., Shaffer A., Kaufmann W.E., Worley P.F., Isakson P., and Markowska A.L. Age-dependent cognitive deficits and neuronal apoptosis in cyclooxygenase-2 transgenic mice. J. Neurosci. 21 (2001) 8198-8209
5. Chen C. ZD7288 inhibits postsynaptic glutamate receptor-mediated responses at hippocampal perforant path-granule cell synapses. Eur. J. Neurosci. 19 (2004) 643-649
6. 2 regulates membrane excitability and synaptic transmission in hippocampal CA1 pyramidal neurons. J. Neurophysiol. 93 (2005) 929-941
7. 2 signaling in hippocampal long-term synaptic plasticity. J. Neurophysiol. 87 (2002) 2851-2857
8. Chevaleyre V., Takahashi K.A., and Castillo P.E. Endocannabinoid-mediated synaptic plasticity in the CNS. Annu. Rev. Neurosci. 29 (2006) 37-76
9. Diana M.A., and Marty A. Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE). Br. J. Pharmacol. 142 (2004) 9-19
10. Freund T.F., Katona I., and Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev. 83 (2003) 1017-1066
11. Katona I., Urban G.M., Wallace M., Ledent C., Jung K.M., Piomelli D., Mackie K., and Freund T.F. Molecular composition of the endocannabinoid system at glutamatergic synapses. J. Neurosci. 26 (2006) 5628-5637
12. Kaufmann W.E., Worley P.F., Pegg J., Bremer M., and Isakson P. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 2317-2321
13. Kim J., and Alger B.E. Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. Nat. Neurosci. 7 (2004) 697-698
14. Kozak K.R., Rowlinson S.W., and Marnett L.J. Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glycerol prostaglandins by COX-2. J. Biol. Chem. 275 (2000) 33744-33749
15. Kozak K.R., Crews B.C., Morrow J.D., Wang L.H., Ma Y.H., Weinander R., Jakobsson P.J., and Marnett L.J. Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides. J. Biol. Chem. 277 (2002) 44877-44885
16. Kozak K.R., Prusakiewicz J.L., and Marnett L.J. Oxidative metabolism of endocannabinoids by COX-2. Curr. Pharm. Des. 10 (2004) 659-667
17. Mackie K. Cannabinoid receptors as therapeutic targets. Annu. Rev. Pharmacol. Toxicol. 46 (2006) 101-122
18. Murray H.J., and O'Connor J.J. A role for COX-2 and p38 mitogen activated protein kinase in long-term depression in the rat dentate gyrus in vitro. Neuropharmacology 44 (2003) 374-380
19. 2 mobilizes calcium and activates signal transduction in RAW 264.7 cells. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 1840-1845
20. Piomelli D. The molecular logic of endocannabinoid signaling. Nat. Rev. Neurosci. 4 (2003) 873-884
21. Robbe D., Kopf M., Remaury A., Bockaert J., and Manzoni O.J. Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 8384-8388
22. Sang N., and Chen C. Lipid signaling and synaptic plasticity. Neuroscientist 12 (2006) 425-434
23. 2 EP2 receptor. J. Neurosci. 25 (2005) 9858-9870
24. 2 glycerol ester, a COX-2 oxidative metabolite of 2-arachidonoyl glycerol, modulates hippocampal inhibitory synaptic transmission. J. Physiol. (Lond) 752 (2006) 735-745
25. Sang N., Zhang J., and Chen C. COX-2 oxidative metabolite of endocannabinoid 2-AG enhances excitatory glutamatergic synaptic transmission and induces neurotoxicity. J. Neurochem. 102 (2007) 1966-1977
26. Slanina K.A., and Schweitzer P. Inhibition of cyclooxygenase-2 elicits a CB1-mediated decrease of excitatory transmission in rat CA1 hippocampus. Neuropharmacology 49 (2005) 653-659
27. Slanina K.A., Roberto M., and Schweitzer P. Endocannabinoids restrict hippocampal long-term potentiation via CB1. Neuropharmacology 49 (2005) 660-668
28. Stella N. Cannabinoid signaling in glial cells. Glia 48 (2004) 267-277
29. Stella N., Schweitzer P., and Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature 388 (1997) 773-777
30. Sugiura T., Kishimoto S., Oka S., Gokoh M., and Wake K. Metabolism and physiological significance of anandamide and 2-arachidonoylglycerol, endogenous cannabinoid receptor ligands. In: Fonteh A.N., and Wykle R.L. (Eds). Arachidonate Remodeling and Inflammation (2004), Birkhäuser Verlag, Basel, Switzerland 211-237
31. Sugiura T., kishimoto S., Oka S., and Gokoh M. Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. Prog. Lipid Res. 45 (2006) 405-446
32. Vereker E., Campbell V., Roche E., McEntee E., and Lynch M.A. Lipopolysaccharide inhibits long term potentiation in the rat dentate gyrus by activating caspase-1. J. Biol. Chem. 275 (2000) 26252-26258
33. Wilson R.I., and Nicoll R.A. Endogenous cannabinoids mediate retrograde signaling at hippocampal synapses. Nature 410 (2001) 588-592
34. Wilson R.I., and Nicoll R.A. Endocannabinoids signaling in the brain. Science 296 (2002) 678-681
35. Yamagata K., Andreasson K.I., Kaufmann W.E., Barnes C.A., and Worley P.F. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 11 (1993) 371-386
36. Yoshida T., Fukaya M., Uchigashima M., Miura E., Kamiya H., Kano M., and Watanabe M. Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. J. Neurosci. 26 (2006) 4740-4751
37. Yu M., Ives D., and Ramesha C.S. Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2. J. Biol. Chem. 272 (1997) 21181-21186
38. Zucker R.S. Short-term synaptic plasticity. Annu. Rev. Neurosci. 12 (1989) 13-31